维普中文期刊产品整合服务
13篇 您的检索式:作者名="MOULD DR"
    题名 作者 年代 出处 被引量
1Population pharmacokinetics- pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response 显示文摘Mould DR Baumaan A Kuhlmann J 2007Br J Clin Pharmacol2007,64,3:1
2Anti-TNF monoclonal antibodies in inflammatory bowel disease:pharmacokinetics-based dosing paradigms显示文摘Ord(a)s I Mould DR Feagan BG Sandborn WJ 0,,04:1
3The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development显示文摘Mould DR Sweeney KR 2007Curr Opin Drug Discov Devel2007,10,1:1
4Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinctics-based dosing paradigms显示文摘ORDAS I MOULD DR FEAOAN BG 2012Clin Pharmacol Ther2012,91,4:1
5Model-based meta-analysis: an important tool for making quantitative decisions during drug de- velopment 显示文摘Mould DR 2012Clin Pharmacol Ther2012,92,3:1
6Using disease progression models as a tool to detect drug effect显示文摘MOULD DR DENMAN NG DUFFULL S 2007Clin Pharmacol Ther2007,82,1:1
7Population pharmacokinetics and pharmacodynamics of CP-101, 606 follow- ing a 72-hour infusion in acute ischemic stroke patients显示文摘TAYLOR T MOULD DR BENINCOSA LJ 2004Clin Pharmacol Ther2004,75,2:1
8Apopulation pharmacokinenetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodhkin' s or Hodgkin's lymphoma显示文摘Mould DR Sweeney K Dufull SB 2009Clin Pharmacol Ther2009,86,2:1
9Modeling and simulation of abatacept exposure and interleukin-6 response in support of recommended doses for rheu- matoid arthritis显示文摘Roy A Mould DR Wang XF 2007J Clin Pharmacol2007,47,11:1
10A population pharmacokinetic and pharmaco-dynamic evaluation of Pralatrexate in patients with relapsed or refractory Non-Hodgkin's or Hodgkin's lymphoma显示文摘MOULD DR SWEENEY K DUFFULL SB 2009Clin Pharmacol Ther2009,86,2:1
11A population pharma- cokinetic and phammcodynamic evaluation of pralatrexate in pa- tients with relapsed or refractory non - Hodgkin' s or Hodgkin' s lymphoma 显示文摘Mould DR Sweeney K Duffull SB 2009Clin Pharmacol Ther2009,86,2:1
12The Pharmacokinetics of Biologics:A Primer显示文摘Mould DR 2015Dig Dis2015,33,1:1
13Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors显示文摘Mould DR Holford NH Schellens JH Beijnen JH Hutson PR Rosing H 2002Clin Pharmacol Ther2002,71,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费